Home
关于我们
产品中心
新闻资讯
技术文章
定制合成
联系我们
中文
产品中心
PRODUCTS
Current location:
Home
>>
产品中心
>>
抗体
PRODUCT CLASSIFICATION
News
NEWS
Application of bioactive small molecules in disease research
Green intelligence creates industry trends, Fuzhen Biology promotes low-carbon development of fine chemical industry
The monoclonal antibody industry is developing rapidly, and Fuzhen Biotechnology is improving its supply system for monoclonal antibody related raw materials
The global biopharmaceutical market continues to expand
Molecular building blocks are used as accelerators for the development of new drugs
Structural formula
Art.No.
Name
CAS
Pureness
CFZ03160
Research Grade Setrusumab
1847394-95-9
95%
CFZ03159
Navicixizumab
1638338-43-8
95%
CFZ03158
Mirvetuximab
1453084-36-0
95%
CFZ03157
Research Grade Ifabotuzumab
1234137-51-9
95%
CFZ03156
Timolumab
1073538-99-4
95%
CFZ03155
Laprituximab
1622327-38-1
95%
CFZ03154
Gontivimab
1257358-38-5
95%
CFZ03153
Apamistamab
2097132-02-8
95%
CFZ03152
Domagrozumab
1629605-31-7
95%
CFZ03151
Blontuvetmab
1608112-78-2
95%
Home
<<
1
2
3
4
5
···
3/59
>>
Last
QQ
QQ
Service Hotline:
15111215862
18229892877